This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Kazunori Arai: Innovator in Asthma Treatment
Introduction
Kazunori Arai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the development of treatments for asthma. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to improving healthcare.
Latest Patents
Kazunori Arai holds 2 patents related to an anti-human TSLP receptor antibody. This antibody specifically binds to the human TSLP receptor and inhibits its action, providing a method for preventing or treating asthma. The invention includes a heavy chain variable region and a light chain variable region, which have been studied extensively. The results indicate that this antibody can inhibit the expression of TARC mRNA induced by TSLP and suppress allergic reactions in a monkey antigen sensitization model.
Career Highlights
Kazunori Arai is associated with Astellas Pharma GmbH, where he continues to work on groundbreaking research in immunology and respiratory diseases. His career is marked by a commitment to developing effective therapies that address critical health issues.
Collaborations
Kazunori has collaborated with notable colleagues, including Daisuke Yamajuku and Hiromu Sato. Their combined efforts have contributed to the advancement of innovative treatments in the pharmaceutical industry.
Conclusion
Kazunori Arai's work in developing an anti-human TSLP receptor antibody represents a significant advancement in asthma treatment. His contributions to the field highlight the importance of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile